{"created":"2023-07-27T06:38:37.314408+00:00","id":26751,"links":{},"metadata":{"_buckets":{"deposit":"0d61cc8b-8994-41cd-b3e1-360fc9883ffe"},"_deposit":{"created_by":3,"id":"26751","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"26751"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00026751","sets":["1761:1762:1763"]},"author_link":["22059","22233","21811","45133","45134","310"],"item_4_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2003-06-10","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"269","bibliographicPageStart":"263","bibliographicVolumeNumber":"29","bibliographic_titles":[{"bibliographic_title":"医療薬学 = Japanese Journal of Pharmaceutical Health Care and Sciences"}]}]},"item_4_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"We evaluated the disposition kinetics of taxanes, an antitumor agent after the intraperitoneal administration in nine patients with peritoneal tumors. The intraperitoneal concentrations of docetaxel or paclitaxel decreased slowly following the i.p. infusion administration of either docetaxel (60-80mg/day) or paclitaxel (120-180mg/ day) over a 1-hour period in patients. There was no difference in the concentration-time courses between both drugs in each patient, and the elimination half-time was about 8hr. The area under the intraperitoneal concentration-time curve (AUCp) of paclitaxel relative to the dose was about 3-times larger than that of docetaxel. On the other hand, the permeability of these drugs from the peritoneal cavity into the systemic circula-tion was extremely small. The plasma concentrations and the AUCs of both drugs showed large individual variations among the patients. The ratios of AUCs/AUCp of docetaxel and paclitaxel relative to the dose were 7.1 ×10-2and 3.8×10-3, respectively. The permeability of paclitaxel was only about 1/20 that of docetaxel.","subitem_description_type":"Abstract"}]},"item_4_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本医療薬学会 = Japanese Society of Pharmaceutical Health Care and Sciences"}]},"item_4_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.5649/jjphcs.29.263","subitem_relation_type_select":"DOI"}}]},"item_4_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.jsphcs.jp/","subitem_relation_type_select":"URI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://www.jstage.jst.go.jp/browse/jjphcs/-char/ja/","subitem_relation_type_select":"URI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://ci.nii.ac.jp/naid/110001166692/","subitem_relation_type_select":"URI"}}]},"item_4_rights_23":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright © JSPHCS Japanese Society of Pharmaceutical Health Care and Sciences"}]},"item_4_source_id_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_source_identifier":"AA11527197","subitem_source_identifier_type":"NCID"}]},"item_4_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1346-342X","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"古居, 奈歩"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"山崎, 賢"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"横川, 弘一"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"伏田, 幸夫"}],"nameIdentifiers":[{},{},{},{}]},{"creatorNames":[{"creatorName":"三輪, 晃一"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"宮本, 謙一"}],"nameIdentifiers":[{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-05"}],"displaytype":"detail","filename":"HO-PR-MIYAMOTO-K-263.pdf","filesize":[{"value":"1.1 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"HO-PR-MIYAMOTO-K-263.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/26751/files/HO-PR-MIYAMOTO-K-263.pdf"},"version_id":"256e4fcb-7c14-4ead-9809-8f63a394e65d"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"腹膜播種患者に対するタキサン系抗癌剤の腹腔内投与時における腹水および血漿中濃度推移","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"腹膜播種患者に対するタキサン系抗癌剤の腹腔内投与時における腹水および血漿中濃度推移"},{"subitem_title":"Ascites and the Plasma Concentration-Time Courses of the Taxanes Antitumor Agents Taxanes after an Intraperitoneal Administration in Patients with Peritoneal Tumors","subitem_title_language":"en"}]},"item_type_id":"4","owner":"3","path":["1763"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-05"},"publish_date":"2017-10-05","publish_status":"0","recid":"26751","relation_version_is_last":true,"title":["腹膜播種患者に対するタキサン系抗癌剤の腹腔内投与時における腹水および血漿中濃度推移"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-07-27T21:19:33.452020+00:00"}